Varenicline effects on craving, cue reactivity, and smoking reward

RATIONALE: Varenicline is an α4β2 nicotinic acetylcholine receptor partial agonist that has been found to be effective for treating tobacco dependence. However, the subjective and behavioral mediators of its efficacy are not known. OBJECTIVES: Using multiple sessions of laboratory-based assessment,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Psychopharmacology (Berl)
Main Authors: Brandon, Thomas H., Drobes, David J., Unrod, Marina, Heckman, Bryan W., Oliver, Jason A., Roetzheim, Richard C., Karver, Sloan Beth, Small, Brent J.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4667942/
https://ncbi.nlm.nih.gov/pubmed/21559801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-011-2327-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki